Bank of New York Mellon Corp Cuts Stake in Acadia Healthcare Company, Inc. $ACHC

Bank of New York Mellon Corp lowered its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 8.4% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 879,967 shares of the company’s stock after selling 80,483 shares during the period. Bank of New York Mellon Corp owned about 0.96% of Acadia Healthcare worth $19,966,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in the business. Citigroup Inc. grew its stake in shares of Acadia Healthcare by 5,144.2% during the first quarter. Citigroup Inc. now owns 2,376,209 shares of the company’s stock valued at $72,047,000 after buying an additional 2,330,898 shares during the last quarter. Hawk Ridge Capital Management LP boosted its holdings in Acadia Healthcare by 437.5% during the 1st quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company’s stock valued at $74,988,000 after acquiring an additional 2,013,126 shares during the period. Abrams Bison Investments LLC bought a new position in Acadia Healthcare during the 1st quarter worth approximately $55,182,000. Maverick Capital Ltd. increased its stake in Acadia Healthcare by 116.3% in the 1st quarter. Maverick Capital Ltd. now owns 2,246,923 shares of the company’s stock worth $68,127,000 after purchasing an additional 1,208,296 shares during the period. Finally, Nuveen LLC bought a new stake in Acadia Healthcare in the first quarter valued at approximately $20,827,000.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $16.02 on Monday. Acadia Healthcare Company, Inc. has a 1 year low of $15.68 and a 1 year high of $47.08. The stock has a market capitalization of $1.48 billion, a P/E ratio of 10.61, a P/E/G ratio of 4.56 and a beta of 0.97. The company’s 50-day moving average is $22.72 and its 200 day moving average is $22.62. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.01. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The business had revenue of $851.57 million for the quarter, compared to analysts’ expectations of $852.43 million. During the same period in the previous year, the firm posted $0.91 EPS. The business’s revenue was up 4.4% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. On average, sell-side analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have recently issued reports on ACHC shares. Wall Street Zen upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Sunday, August 3rd. Guggenheim cut their price target on shares of Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating on the stock in a report on Monday, November 10th. Cantor Fitzgerald decreased their price objective on shares of Acadia Healthcare from $25.00 to $22.00 and set a “neutral” rating on the stock in a research report on Friday, November 7th. Royal Bank Of Canada dropped their target price on shares of Acadia Healthcare from $28.00 to $22.00 and set an “outperform” rating for the company in a report on Wednesday, November 12th. Finally, UBS Group reduced their price target on Acadia Healthcare from $31.00 to $28.00 and set a “buy” rating on the stock in a report on Friday, November 7th. Eight investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $32.82.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.